Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antimalarial drug efficacy for uncomplicated Plasmodium falciparum malaria
PACTR202309773069812Completed
- Sponsor
- University of Gondar
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of artemether + lumefantrine in malaria and Malaria, sponsored by University of Gondar. Primary endpoint: Adequate clinical and parasitological response. Started Sep 2022; status: completed.
02
Drugs
artemether + lumefantrine
03
Conditions
malariaMalaria
Beyond the preview
Go deeper on PACTR202309773069812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202309773069812.